Machine Learning Models for Human

Humans Machine Learning Models, Biological Pharmacokinetics
clinical data compound design human pharmacokinetics machine learning pharmacokinetic modeling structure−property relationships

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
06 12 2021
Historique:
pubmed: 12 11 2021
medline: 15 3 2022
entrez: 11 11 2021
Statut: ppublish

Résumé

Prior to clinical development, a comprehensive pharmacokinetic characterization of a novel drug is required to understand its exposure at the site of action and elimination. Accordingly,

Identifiants

DOI: 10.1021/acs.molpharmaceut.1c00718 PMID: 34758626
pubmed: 34758626
doi: 10.1021/acs.molpharmaceut.1c00718
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4520-4530

Auteurs

Filip Miljković (F)

Data Science and AI, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg SE-43183, Sweden.
ORCID: 0000-0001-5365-505X

Anton Martinsson (A)

Data Science and AI, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg SE-43183, Sweden.

Olga Obrezanova (O)

Data Science and AI, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.

Beth Williamson (B)

Drug Metabolism and Pharmacokinetics, Research and Early Development, Oncology, R&D, AstraZeneca, Cambridge CB10 1XL, U.K.

Martin Johnson (M)

Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge SG8 6HB, U.K.

Andy Sykes (A)

Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge SG8 6HB, U.K.

Andreas Bender (A)

Data Science and AI, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge CB2 1EW, U.K.
ORCID: 0000-0002-6683-7546

Nigel Greene (N)

Data Science and AI, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Machine Learning Models for Human
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Algorithmes › Intelligence artificielle › Apprentissage machine › Machine Learning Models for Human
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Machine Learning Models for Human
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Pharmacocinétique › Machine Learning Models for Human